Delivery Order SPE2DR25D2006-SPE2DR26F55XF
Award Date 11/4/25
Potential Completion Date 11/5/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,458.48 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. This firm fixed-price, non-set-aside contract was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Teriparatide is a hormone-based medication used primarily for osteoporosis treatment,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,422.77 to AmerisourceBergen Drug Corp for Teriparatide 560 MCG/2.24 ML pen injections on August 18, 2025, with a completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $26,852.75 delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. This contract represents a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid hormone used in...
- The Defense Logistics Agency awarded a $2,753.64 delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, with a completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections, valued at $56,123.17. This is a firm fixed-price delivery order with no set-aside designation, utilizing open competition. The order is scheduled for completion by October 28, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 6, 2025, for the supply of Teriparatide 560 mcg/2.24 mL pen injections, valued at $13,541.58. This firm fixed-price, competitively awarded contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. The delivery order carries no set-aside designation and represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,156.03 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, with a completion date of May 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a $51,334.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, with performance in Conshohocken, Pennsylvania and a completion date of September 4, 2025. This non-set-aside delivery order was competitively awarded and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. Teriparatide is a recombinant human...
- The Defense Logistics Agency awarded a delivery order valued at $41,615.46 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24mL pen injections. The contract, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $14,317.78 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections. This is a firm fixed-price, non-set-aside contract with a completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid hormone used primarily in the treatment of osteoporosis and bone-related conditions. This...